A High Performance Agent-Based System for Reporting Suspected Adverse Drug Reactions

Adverse drug reactions (ADRs) represent a serious worldwide problem. Current post-marketing ADR detection approaches largely rely on spontaneous reports filed by various healthcare professionals such as physicians, pharmacists et.al.. Underreporting is a serious deficiency of these methods - the actually reported adverse events represent less than 10% of… CONTINUE READING